Washington, DC: "Research into the analgesic and anti-inflammatory effects of cannabis continued to bolster the case for the medicinal use of marijuana, making the patient pot laws' that have passed in 11 states seem less like a social movement than a legitimate medical trend," states last week's issue of Time Magazine.
The magazine cited a pair of recent studies investigating the use of medicinal cannabinoids. The first, published last month in the journal Rheumatology, found that cannabis extracts reduced pain and inflammation and improved sleep in patients suffering from rheumatoid arthritis.
Time also cited a previous preclinical trial published in the Journal of Neuroscience that found that the administration of synthetic cannabinoids in both animals and in human brain tissue prevented the neurodegenerative decline associated with Alzheimer's disease.
Clinical reviews published by the Society for Neuroscience and in the journal Physical Medicine and Rehabilitation Clinics of North America, among others, have also noted that cannabinoids may be clinically useful in the treatment of several neurodegenerative disorders, including Alzheimer's, amyotrophic lateral sclerosis (ALS), and Parkinson's disease.
For more information, please contact Paul Armentano, NORML Senior Policy Analyst, at (202) 483-5500.